Concord Biotech Successfully Completes ANVISA Inspection at Limbasi API Manufacturing Facility
Concord Biotech has successfully completed an ANVISA inspection at its Limbasi Active Pharmaceutical Ingredient (API) manufacturing facility, strengthening its regulatory standing and expansion into Brazil's pharmaceutical market.
Brazilian Health Regulatory Agency | 12/06/2026 | By News Bureau
India, Brazil Ink MoU to Deepen Regulatory Cooperation in Pharma and Medical Products
India’s CDSCO and Brazil’s ANVISA exchanged MoU in the presence of Prime Minister Narendra Modi and President Luiz Inácio Lula da Silva to strengthen regulatory cooperation in pharmaceuticals and medical products.
Brazilian Health Regulatory Agency | 23/02/2026 | By News Bureau | 145
Akums' Haridwar Sterile Facility Receives GMP Certificate from Brazil's ANVISA
Akums Drugs and Pharmaceuticals has announced that its sterile manufacturing plant in Haridwar, Uttarakhand, has been awarded the Good Manufacturing Practice (GMP) certificate from ANVISA, the Brazilian health regulatory agency.
Brazilian Health Regulatory Agency | 28/07/2025 | By Dineshwori | 922
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy